This bill seeks to address Premenstrual Dysphoric Disorder (PMDD), a severe and often disabling condition affecting a significant portion of reproductive-aged individuals, which is currently under-diagnosed, under-researched, and stigmatized. It emphasizes the need for early detection, effective treatment, and increased public and provider awareness to improve the quality of life for those affected. The legislation mandates the Secretary of Health and Human Services, through the National Institutes of Health, to expand and intensify research into PMDD's causes, risk factors, diagnosis, and treatment. This includes supporting clinical trials for improved treatment options and ensuring diverse representation in all PMDD-related research. The Secretary is also directed to collect and publish data on PMDD prevalence, its economic and workforce impact, and barriers to diagnosis and treatment. To improve awareness, the Secretary must launch a public health campaign to educate patients and healthcare providers on PMDD symptoms and treatment, reduce stigma, and encourage timely medical care. Furthermore, the Health Resources and Services Administration will develop and disseminate continuing medical education materials to equip providers with the knowledge to accurately diagnose PMDD, differentiate it from other conditions, and offer evidence-based care. The bill authorizes grants to eligible entities, such as accredited medical and nursing schools or hospitals, to develop or expand training programs for various health professionals. These programs aim to improve the care, treatment, and management services for PMDD, including expanding training opportunities for primary and specialty care services related to mid-life women's health and early detection of perimenopause and menopausal symptoms. Finally, the Secretary is required to submit a report to Congress within two years on the progress made in expanding PMDD research, improving awareness and education, and increasing access to diagnosis and treatment.